Life Sciences R&D Tax Credits: Form 6765 Changes
カートのアイテムが多すぎます
ご購入は五十タイトルがカートに入っている場合のみです。
カートに追加できませんでした。
しばらく経ってから再度お試しください。
ウィッシュリストに追加できませんでした。
しばらく経ってから再度お試しください。
ほしい物リストの削除に失敗しました。
しばらく経ってから再度お試しください。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
Life Sciences R&D Tax Credits: Form 6765 Changes
-
ナレーター：
-
著者：
New Reporting Requirements and Compliance Strategies
In this episode of the Healthcare & Life Sciences Podcast, hosts Adam Hunter, Assurance Services Partner, and Carolyn Smith Driscoll, Tax Credits & Incentives Advisory, continue the conversation around R&D tax credits, focusing on the evolving reporting and documentation requirements. Together, they discuss the IRS's revised Form 6765 and the shift toward project-level reporting.
Tune in to learn more about:
- Key changes to Form 6765 and how they are reshaping R&D tax credit reporting requirements.
- The new business component reporting requirements and why project-level tracking is becoming increasingly important.
- What effective documentation looks like and how companies can support their claims with audit-ready records.
- The practical impact of enhanced IRS reporting expectations on life sciences organizations.
- Steps companies can take today to prepare for future compliance requirements and strengthen their R&D credit processes.
Join the conversation for insights on what life sciences companies need to do now to strengthen documentation, improve compliance, and prepare for increased scrutiny of R&D credit claims.
Questions? Contact Us: https://www.cbh.com/contact/connect-me-with-a-professional/
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません